Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients-Reference-Cited by-同舟云学术

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients

Published:2015-01-28 Issue:3 Volume:61 Page:790-801
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Meissner Eric G.¹,Lee Yu‐Jin¹,Osinusi Anu¹²,Sims Zayani³,Qin Jing¹,Sturdevant Dan⁴,McHutchison John⁵,Subramanian Mani⁵,Sampson Maureen⁶,Naggie Susanna⁷,Patel Keyur⁷,Remaley Alan T.⁶,Masur Henry³,Kottilil Shyam¹

Affiliation:

1. Laboratory of ImmunoregulationNational Institute of Allergy and Infectious Diseases, National Institutes of HealthBethesda MD

2. Division of Infectious DiseasesInstitute of Human Virology, University of Maryland Medical SchoolBaltimore MD

3. Critical Care Medicine Department, Clinical CenterNational Institutes of HealthBethesda MD

4. Genomics Unit, Research Technologies Section, Rocky Mountain LaboratoriesNational Institute of Allergy and Infectious Diseases, National Institutes of HealthHamilton MT

5. Gilead SciencesFoster City CA

6. Lipoprotein Metabolism SectionNational Heart, Lung, and Blood Institute, National Institutes of HealthBethesda MD

7. Duke University, Duke Clinical Research InstituteDurham NC

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.27424

Reference48 articles.